Orchestra BioMed Holdings, Inc. (OBIO) stock
OBIONasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$7.46+0.49 (+7.03%)
Close on Nov 18, 2026Market cap $448.38MP/E –Yield –
Orchestra BioMed revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Orchestra BioMed's revenue for the twelve months ending Jun 30, 2026 was $31.98M, up 986.1% year over year. For fiscal 2025 it was $33.48M, up 1169.2% from the year before.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $33.48M | +1169.2% |
| FY2024 | Dec 31, 2024 | $2.64M | -4.4% |
| FY2023 | Dec 31, 2023 | $2.76M | -21.9% |
| FY2022 | Dec 31, 2022 | $3.53M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $88.00K | -89.5% |
| Q1 FY2026 | Mar 31, 2026 | $110.00K | -87.3% |
| Q4 FY2025 | Dec 31, 2025 | $30.92M | +12120.2% |
| Q3 FY2025 | Sep 30, 2025 | $861.00K | -12.8% |
| Q2 FY2025 | Jun 30, 2025 | $836.00K | +7.5% |
| Q1 FY2025 | Mar 31, 2025 | $868.00K | +40.0% |
| Q4 FY2024 | Dec 31, 2024 | $253.00K | -3.4% |
| Q3 FY2024 | Sep 30, 2024 | $987.00K | +135.6% |
| Q2 FY2024 | Jun 30, 2024 | $778.00K | -15.0% |
| Q1 FY2024 | Mar 31, 2024 | $620.00K | -46.7% |
| Q4 FY2023 | Dec 31, 2023 | $262.00K | -76.2% |
| Q3 FY2023 | Sep 30, 2023 | $419.00K | -64.0% |
| Q2 FY2023 | Jun 30, 2023 | $915.00K | +128.2% |
| Q1 FY2023 | Mar 31, 2023 | $1.16M | +34.4% |
| Q4 FY2022 | Dec 31, 2022 | $1.10M | – |
| Q3 FY2022 | Sep 30, 2022 | $1.16M | – |
| Q2 FY2022 | Jun 30, 2022 | $401.00K | – |
| Q1 FY2022 | Mar 31, 2022 | $866.00K | – |
See a number that looks wrong?